FedEx shares tumble amid weak demand for priority deliveries

(Reuters) - FedEx Corp (NYSE:FDX ) shares slumped on Friday after the parcel giant cut its annual revenue forecast and reported a sharp fall in profits, owing to weak demand for high-margin speedy delivery services.

Shares of the company were down nearly 13% in premarket trading, with rival UPS down 2.4%.

FedEx, which is seen as a bellwether for worldwide economic trade, attributed the fall in its profits to waning demand for priority shipments between businesses as customers try to curb expenses.

CEO Raj Subramaniam said industrial demand was softer than expected.

The company now expects revenue for fiscal 2025 to grow by a low single-digit percentage compared with a low-to-mid single-digit percentage growth it forecast earlier.

FedEx also lowered the top end of its full-year adjusted operating income to between $20 and $21 per share, versus its previous range of $20 to $22 per share.

"The lower end of the EPS range reflects assumptions that the pricing environment continues to be very competitive and the industrial economy remains challenged," Baird analyst Garrett Holland wrote in a note.

The Memphis, Tennessee-based company said first-quarter results were negatively affected by a change in service preferences, with reduced demand for priority services, increased demand for deferred services and constrained yield growth.

FedEx is also in the process of winding down its contract work for the United States Postal Service, its biggest client, and anticipates a $500 million decline in revenue from the contract loss in the current fiscal year.



Meanwhile, the company has embarked on a complex restructuring that aims to slash billions of dollars in overhead costs and drive operational efficiencies, which analysts say will continue to bear fruit.

"There is some room for optimism, assuming that savings from 'DRIVE' accelerate throughout the rest of the year and pricing power picks up during peak season," J.P.Morgan analyst Brian P. Ossenbeck wrote in a research note.

Source: Investing.com

Останні публікації
Sanofi's tolebrutinib drug delays progressive MS by 31% in trial
20.09.2024 - 15:00
Factbox-US companies to hire thousands of seasonal workers for holiday season
20.09.2024 - 15:00
FedEx, PepsiCo, Trump Media fall premarket; Nike rises
20.09.2024 - 15:00
Vietnamese EV maker VinFast reports wider sequential gross loss
20.09.2024 - 15:00
PepsiCo cut at Morgan Stanley as 'fundamental struggles continue'
20.09.2024 - 15:00
Here's how the stock market typically performers in October
20.09.2024 - 15:00
Nike's new CEO may look to mend retailer ties in sales revival push
20.09.2024 - 15:00
Nokia says German court rules in its favour in patent dispute with Amazon
20.09.2024 - 15:00
US stock index futures consolidate after strong gains; FedEx slides
20.09.2024 - 14:00
GM to recall over 449,000 pickup trucks, SUVs in US
20.09.2024 - 14:00
Analysis-Brazil’s online gambling craze may be hitting consumer spending
20.09.2024 - 14:00
Huawei 'super fans' fuming as left empty handed by $2,800 phone launch
20.09.2024 - 14:00
How the S&P 500 traded after the first rate cut ahead of the past 2 recessions
20.09.2024 - 14:00
India stocks higher at close of trade; Nifty 50 up 1.48%
20.09.2024 - 14:00
HomesToLife Files for 1.25M Share IPO at $4-$6/sh
20.09.2024 - 14:00

© Analytic DC. All Rights Reserved.

new
Аналіз трейдера Аналіз трейдера за 20.09.24
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.